Skip to content
HomeLatest newsWhat you need to know about Johnson & Johnson’s 2020 second-quarter earnings
lede-What You Need to Know About Johnson & Johnson's 2020 Second-Quarter Earnings.jpg

What you need to know about Johnson & Johnson’s 2020 second-quarter earnings

Check out this infographic breakdown of the company’s second-quarter 2020 performance, with key highlights from its pharmaceutical, consumer and medical devices businesses.

Share Article
share to
Inset - Quarterly Earnings Ribbon

This morning, Johnson & Johnson shared its second-quarter performance.

Since its founding in 1886, the company has grown to become one of the world’s largest and most broadly based healthcare companies, with approximately 132,000 employees across the globe working every day to help change the trajectory of health for humanity.

“The resilience of our diversified business has enabled us to continue delivering value to our stakeholders, even in the face of the COVID-19 global pandemic,” says Joseph Wolk, Executive Vice President, Chief Financial Officer, Johnson & Johnson. “This sustainability, coupled with Johnson & Johnson’s rich history of being at the forefront of scientific innovation, public health and global community impact, reinforces our long-term business outlook, and motivates our colleagues and partners to responsibly develop and provide a safe, effective and affordable vaccine to people around the world as soon as possible.”

For more details about the company’s 2020 second-quarter results, and to read a message from Chairman and Chief Executive Officer Alex Gorsky, here’s an infographic that highlights key stats.


Q2 2020 Johnson & Johnson Earnings infographic

Johnson & Johnson’s 2020 2nd-Quarter Earnings

Read the earnings press release, which includes full financial details for the second quarter of 2020.

Want to see more company earnings information? Find Johnson & Johnson’s past quarterly and full-year results here.

More from Johnson & Johnson

What to know about We All Belong: 2023 DEI Impact Review

The annual report details how Johnson & Johnson is harnessing the power of diversity, equity and inclusion to provide better care around the world.

Giving the gift of sight

In Kenya, around 1.5 million people—including children—contend with visual impairment or blindness. Sight For Kids, Johnson & Johnson’s global eye-care partnership, is devoted to changing these stats, one vision screening at a time.

Inside the development of a revolutionary treatment for blood cancers

In 2014, a Johnson & Johnson therapy gained approval for the treatment of a type of B-cell malignancy—increasing survival rates and changing the way scientists approach cancer treatment. These 8 milestone moments tell the transformational story.
You are now leaving jnj.com. The site you’re being redirected to is a branded pharmaceutical website. Please click below to continue to that site.